Nanotechnology Cancer Detection Technology Moves To Clinical Trial
This article was originally published in The Gray Sheet
Executive Summary
A first-in-man clinical trial to measure very small levels of residual leukemia cells using a unique nanotechnology-based magnetic imaging method has enrolled its first 35 patients.